Loading...

Home
Stock
AKAN

AKAN Overview

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Stock Price Prediction Technical Valuation Financials Earnings Should I Buy News & Events

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

Loading chart...

High

14.050

Open

13.900

VWAP

13.31

Vol

31.87K

Mkt Cap

7.39M

Low

12.232

Amount

424.33K

EV/EBITDA(TTM)

--

Total Shares

540.84K

EV

19.91M

EV/OCF(TTM)

--

P/S(TTM)

14.70

Akanda Corp. is a United Kingdom-based company. The Company is a cannabis & hemp cultivation, manufacturing and distribution company. Its segments include Cultivation, Distribution & Corporate. The Cultivation segment is focused on the cultivation of medical cannabis and medical cannabis biomass. The Distribution segment undertakes the sale and distribution of medical cannabis products. The Corporate segment undertakes management and treasury services.

Show More

Events Timeline

(ET)

2026-05-20

10:30:00

Akanda Corp Trading Resumes

2026-05-20

10:20:00

Akanda Corp Trading Halted Due to Volatility

2026-05-06 (ET)

2026-05-06

10:10:00

Akanda Corp Trading Resumes

2026-05-06

10:00:00

Akanda Corp Trading Halted Due to Volatility

2026-05-04 (ET)

2026-05-04

12:00:00

Akanda Corp Trading Halted Due to Volatility

2026-05-01 (ET)

2026-05-01

09:50:00

Akanda Corp Trading Resumes

2026-05-01

09:50:00

Akanda Corp Trading Halted Due to Volatility

2026-04-30 (ET)

2026-04-30

12:30:00

Akanda Corp Trading Halted Due to Volatility

News

Newsfilter

06-12Newsfilter

Nokia Accelerates Transformation Amid Strong AI Demand

Upgraded Growth Outlook: Nokia recently reported strong demand from AI and cloud customers, with approximately €1 billion in new orders, prompting management to raise its Network Infrastructure growth outlook from 6%-8% to 12%-14%, reflecting robust performance in optical and IP networking.
Strategic Investment Boost: The strategic investment from NVIDIA further solidifies Nokia's position in the rapidly growing AI infrastructure market, particularly in the construction of hyperscale data centers that require high-performance optical connectivity.
Stock Price Surge: Following earnings results that exceeded expectations, Nokia's shares reached their highest levels in nearly 16 years, indicating strong market confidence in its transformation strategy.
Biotech Investment Interest: NeOnc Technologies Holdings continues to attract speculative biotech investors focused on central nervous system oncology, with its development of therapies for glioblastoma and a recent $5 million private placement generating significant market interest.

stocktwits

06-12stocktwits

Akanda Regains Nasdaq Compliance Amid Stock Surge

Stock Split Impact: In April, Akanda executed a 1-for-4.5 reverse stock split, reducing outstanding shares from approximately 2.4 million to 534,000, aimed at increasing share price to meet Nasdaq listing requirements.
Compliance Issue Resolved: The company filed its annual report for fiscal year 2025 with the SEC on June 9, successfully addressing a Nasdaq noncompliance notice issued on May 20, marking a return to compliance.
Positive Market Reaction: Following the compliance announcement, AKAN stock surged 70% in premarket trading, indicating investor optimism about the company's future, despite a 75% decline in stock price over the past year.
Investor Sentiment Shift: On Stocktwits, retail sentiment towards AKAN shifted from 'bearish' to 'neutral', reflecting a positive response to the compliance news, although concerns about the company's fundamental value remain prevalent.

seekingalpha

06-12seekingalpha

Akanda Regains Compliance with Nasdaq Filing Requirements

Compliance Restoration: On Friday, Akanda announced it has regained compliance with Nasdaq by submitting its delayed annual report for fiscal 2025, indicating positive progress in adhering to listing regulations.
Notification Date: Nasdaq notified Akanda on June 10 that it met the requirements of Listing Rule 5250(c)(1), emphasizing the company's efforts in timely report submissions.
Non-Compliance Notice: Prior to this, Akanda received a non-compliance notice from Nasdaq on May 20 for failing to file its Form 20-F annual report for the year ended December 31, 2025, highlighting the challenges faced in compliance.
Report Submission: The company filed the annual report on June 9, after which Nasdaq closed the matter, indicating that Akanda has taken necessary steps to restore compliance, thereby enhancing investor confidence.

Yahoo Finance

06-12Yahoo Finance

Akanda Corp. Regains Nasdaq Compliance with 20-F Filing

Compliance Restoration: On June 10, 2026, Akanda Corp. received written confirmation from Nasdaq that it has regained compliance with Listing Rule 5250(c)(1), indicating the company has timely filed all required financial reports, thus ensuring its compliance in the capital markets.
Report Submission: Nasdaq had previously notified the company on May 20, 2026, regarding non-compliance due to the failure to file the 20-F annual report for the fiscal year 2025, but the company rectified this by submitting the report to the SEC on June 9, 2026, resolving the compliance issue.
Market Confidence Boost: The restoration of compliance not only alleviates potential impacts on the company's stock trading but also enhances investor confidence in Akanda's future growth, potentially attracting more investor interest in its business.
Business Context: Akanda Corp. is focused on cultivating and distributing high-quality cannabis and wellness products through its Canadian subsidiary, aiming to provide safe and reliable products to consumers worldwide while promoting sustainable business practices, reflecting its strategic positioning in a rapidly growing market.

seekingalpha

05-22seekingalpha

Akanda Fails to File Annual Report, Faces Nasdaq Compliance Issues

Compliance Issues: Akanda (AKAN) has failed to meet Nasdaq's periodic filing requirements by not submitting its Form 20-F for the fiscal year ending December 31, 2025, which raises the risk of delisting from Nasdaq.
Stock Price Decline: The company's stock fell nearly 14% in extended trading on Friday, indicating market concerns over its compliance issues, which could negatively impact investor confidence and future financing capabilities.
Remedial Plan Requirement: Akanda is required to submit a plan by July 19, 2026, outlining steps to regain compliance; if accepted by Nasdaq, the company could receive an extension of up to 180 days, until November 16, 2026.
Listing Impact: Although the Nasdaq notice currently has no immediate effect on the listing or trading of Akanda's common shares, failure to regain compliance in a timely manner could lead to delisting, posing significant risks to the company's long-term prospects.

Yahoo Finance

05-22Yahoo Finance

Akanda Corp Cancels Special Shareholder Meeting

Meeting Cancellation: Akanda Corp. announced the cancellation of its special shareholder meeting originally scheduled for May 25, 2026, due to failure to meet quorum requirements, indicating challenges in shareholder engagement that may affect future decision-making transparency and effectiveness.
Insufficient Shareholder Participation: The meeting required at least 10% of outstanding shares to be represented, and the inability to meet this threshold reflects difficulties in attracting investor interest, potentially undermining market confidence in the company.
Business Development Focus: Akanda, through its Canadian subsidiary, aims to cultivate and distribute high-quality cannabis and wellness products to enhance consumer quality of life; however, the cancellation of the meeting may delay the implementation of its strategic initiatives.
Market Expansion Plans: Akanda's wholly-owned subsidiary, First Towers & Fiber Corp., is developing a 700+ km fiber optic network in Mexico with plans to expand into other Latin American countries, showcasing growth potential in the wireless market despite challenges related to shareholder engagement.

Valuation Metrics

The current forward P/E ratio for Akanda Corp (AKAN.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Akanda Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

dotted line Image

N/A

5Y Average PE

0.00

Current PE

0.00

Overvalued PE

0.00

Undervalued PE

0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

dotted line Image

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

dotted line Image

N/A

5Y Average PS

0.00

Current PS

0.00

Overvalued PS

0.00

Undervalued PS

0.00

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

stocks best for day trade

Intellectia · 4 candidates

Price: >= $10.00Volume: >= 5,000,000Rsi Category: moderateRelative Vol: >= 2Beta: HighRiskMoving Average Relationship: PriceAboveMA5, PriceAboveMA20, PriceCrossAboveMA5, PriceBreakResistance

Ticker

Name

Market Cap$

Akanda Corp

10.03M

Roku Inc

21.22B

Enliven Therapeutics Inc

2.81B

Tango Therapeutics Inc

4.48B

Momentum stocks

Intellectia · 1440 candidates

Relative Vol: >= 1.50Moving Average Relationship: PriceAboveMA20, PriceAboveMA200Week Price Change Pct: >= $0.00Month Price Change Pct: >= $0.00Macd: bullish

Ticker

Name

Market Cap$

Akanda Corp

13.89M

Beasley Broadcast Group Inc

34.79M

OneConstruction Group Ltd

136.96M

Maxlinear Inc

6.05B

Republic Power Group Ltd

4.44M

Smart Powerr Corp

23.42M

today's gainers

Intellectia · 58 candidates

Volume: >= -100Price Change Pct: >= $5.00Relative Vol: >= 1.50Monthly Average Dollar Volume: >= -100

Ticker

Name

Market Cap$

Rising Dragon Acquisition Corp

35.41M

Akanda Corp

9.35M

Borealis Foods Inc

24.25M

Sagtec Global Ltd

21.68M

Silicon Motion Technology Corp

5.07B

U-BX Technology Ltd

29.68M

list10 stocks up 5%

Intellectia · 371 candidates

Price Change Pct: >= $5.00

Ticker

Name

Market Cap$

Axe Compute Inc

25.59M

eLong Power Holding Ltd

2.23M

Toro Corp

112.81M

Newsmax Inc

940.13M

Beam Global

32.13M

Xanadu Quantum Technologies Ltd

8.18B

low float high volume medical stock

Intellectia · 22 candidates

Sector: Healthcare, Healthcare Services & Equipment, Pharmaceuticals & Medical ResearchVolume: >= 1,000,000List Exchange: XNYS, XNAS, XASEFloating Shares: <= 30,000,000

Ticker

Name

Market Cap$

Akanda Corp

1.66M

iBio Inc

60.11M

bioAffinity Technologies Inc

21.32M

Azitra Inc

3.82M

Karyopharm Therapeutics Inc

109.27M

Soligenix Inc

12.20M

stocks under $2 that fell 5% or more

Intellectia · 109 candidates

Price: <= $2.00Price Change Pct: <= $-5.00

Ticker

Name

Market Cap$

Psyence Biomedical Ltd

890.11K

IO Biotech Inc

14.94M

Venus Concept Inc

3.51M

Innovation Beverage Group Ltd

3.33M

Jeffs Brands Ltd

2.33M

Surgepays Inc

25.72M

find stocks under $2 that fell 5% or more

Intellectia · 109 candidates

Price: <= $2.00Price Change Pct: <= $-5.00

Ticker

Name

Market Cap$

Psyence Biomedical Ltd

890.11K

IO Biotech Inc

14.94M

Venus Concept Inc

3.51M

Innovation Beverage Group Ltd

3.33M

Jeffs Brands Ltd

2.33M

Surgepays Inc

25.72M

Good cheap stock to buy

Intellectia · 746 candidates

Market Cap: <= 2.00BPrice: <= $10.00Weekly Average Turnover: >= 1,000,000Pe Ttm: <= 15

Ticker

Name

Market Cap$

NewGenIvf Group Ltd

553.20K

Lion Group Holding Ltd

755.53K

Icon Energy Corp

1.57M

Interactive Strength Inc

1.70M

Boxlight Corp

1.73M

Direct Digital Holdings Inc

1.74M

stocks that fell over 20% yesterday

Intellectia · 19 candidates

Price Change Pct: $-100.00 - $-20.00

Ticker

Name

Market Cap$

Psyence Biomedical Ltd

890.11K

IO Biotech Inc

14.94M

Venus Concept Inc

3.51M

Innovation Beverage Group Ltd

3.33M

Jeffs Brands Ltd

2.33M

Surgepays Inc

25.72M

Whales Holding AKAN

Trading Trends

Insider

Hedge Fund

Congress Trading

People Also Watch

Frequently Asked Questions

What is Akanda Corp (AKAN) stock price today?

The current price of AKAN is 13.66 USD — it has decreased -2.98

What is Akanda Corp (AKAN)'s business?

Akanda Corp. is a United Kingdom-based company. The Company is a cannabis & hemp cultivation, manufacturing and distribution company. Its segments include Cultivation, Distribution & Corporate. The Cultivation segment is focused on the cultivation of medical cannabis and medical cannabis biomass. The Distribution segment undertakes the sale and distribution of medical cannabis products. The Corporate segment undertakes management and treasury services.

What is the price predicton of AKAN Stock?

Wall Street analysts forecast AKAN stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for AKAN is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Akanda Corp (AKAN)'s revenue for the last quarter?

Akanda Corp revenue for the last quarter amounts to 41.43K USD, decreased

What is Akanda Corp (AKAN)'s earnings per share (EPS) for the last quarter?

Akanda Corp. EPS for the last quarter amounts to -20330.44 USD, decreased

How many employees does Akanda Corp (AKAN). have?

Akanda Corp (AKAN) has 46 emplpoyees as of June 30 2026.

What is Akanda Corp (AKAN) market cap?

Today AKAN has the market capitalization of 7.39M USD.